Oncolytic Viruses

FLAG Merges with Calidi

The merger looks to create a public company focused on developing oncolytic viral therapies with stem cell-based delivery services.
January 11, 2023
From Our Partners
How Technology Can Increase Deal Flow Up to 5x
In today’s complex, highly competitive dealmaking environment, it’s critical to deploy state-of-the-art technology for M&A and other high-value strategic pursuits.
February 13, 2023